Visual loss in patient on high-dose subcutaneous desferrioxamine.
D002648:Child; D003676:Deferoxamine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D013789:Thalassemia / Q000188:drug therapy; D014786:Vision Disorders / Q000139:chemically induced*
D003676:Deferoxamine